Trademark Overview
On Thursday, April 3, 2025, a trademark application was filed for SAREPTACADEMY with the United States Patent and Trademark Office. The USPTO has given the SAREPTACADEMY trademark a serial number of 99119415. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 3, 2025. This trademark is owned by Sarepta Therapeutics, Inc.. The SAREPTACADEMY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Providing online health information for patients and families of patients via non-downloadable videos; Medical information services provided via the Internet; Providing health information; Providing healthcare information; Providing medical information; Providing a web site featuring medical information; Providing medical information in the field of rare diseases, genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Providing medical information to patients, caregivers, families, and healthcare professionals in the form of reports in the field of navigating a rare disease diagnosis and exploring existing and potential treatment options for rare diseases and genetic diseases and disorders; Providing information about genetic testing for medical purposes; Providi...
Providing information about medical and healthcare research and clinical trials; Providing information to healthcare providers and patients about medical and healthcare research and clinical trials; Providing medical and scientific research information; Providing information about medical and scientific research; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the field of clinical trials; Providing medical research information in the field of rare diseases genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and RNA-based and RNAi-based therapies; Providing scientific research information in the field of rare diseases genetic diseases and disorders, muscular dystrophies, gene therapy products, genetic medicines, PMOs, and R...
